HCPCS Level II code A9155 represents a packaged, dispensed oral moisture substitute — artificial saliva, 30 ml — used to manage symptoms of xerostomia across outpatient and pharmacy settings. Nationally, coverage and reimbursement for small-volume oral lubricants matter because they affect access for patients with dry mouth from medications, radiation therapy, Sjögren’s syndrome, or other causes. Payment policies influence whether patients receive these products through pharmacy benefits, durable medical equipment channels, or medical benefit carve-outs.

Key payers considered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of what the code represents, typical sites of service, and what to expect in payer coverage frameworks. The publication summarizes benchmarks for usage and reimbursement where available, highlights common billing and coding considerations tied to dispensing small-volume oral lubricants, and outlines the clinical context in which A9155 is commonly used. Where detailed payer-specific policy or pricing data are not provided, the report notes that such information is not available in the input and focuses on nationally relevant policy and billing themes.